Core Findings - A recent study from New York University's Global Institute of Public Health indicates that anxiety about aging, particularly concerns over declining health, may manifest at the cellular level and accelerate biological aging in women [1][2] Group 1: Study Overview - The study analyzed data from 726 women participating in the "American Midlife Development Study," assessing their anxiety regarding aging-related issues such as decreased attractiveness, increased health problems, and reduced fertility [1] - Blood samples were collected to measure biological age using two epigenetic "clocks," one capturing the speed of biological aging and the other estimating accumulated biological damage [1] Group 2: Key Results - Women with higher levels of anxiety about aging exhibited significantly faster epigenetic aging, with concerns about health deterioration showing the strongest association with accelerated aging [1] - In contrast, anxiety related to decreased attractiveness and changes in fertility did not show a significant correlation with biological aging [1] Group 3: Lifestyle Factors and Implications - Further analysis revealed that when controlling for health behaviors such as smoking and drinking, the association between aging anxiety and epigenetic aging weakened, suggesting that lifestyle factors may play a significant role [2] - The researchers emphasized the close relationship between psychological and physiological health throughout a person's life, proposing that aging anxiety could be a measurable psychological factor with intervention potential [2]

Core Viewpoint - The article discusses the development of a robust computational framework called MAPLE for predicting methylation age and disease risk, which addresses the limitations of traditional epigenetic clocks and has significant potential for clinical applications in aging and health management [3][4][26]. Group 1: Background and Need for MAPLE - Aging is characterized by increased morbidity and declining quality of life, creating significant social and economic burdens [2]. - Breakthrough research indicates that interventions like caloric restriction and epigenetic reprogramming can extend lifespan and healthspan, but precise quantification of biological age and aging rate is necessary for clinical application [2]. - DNA methylation (DNAm) changes are key markers of aging, with whole-genome DNAm serving as a potential biological age assessment tool [2]. Group 2: MAPLE Development and Performance - MAPLE employs pairwise learning to determine the relative relationship between two DNA methylation profiles regarding age or disease risk, effectively reducing technical biases while identifying biological signals related to aging or disease [4][9]. - In 31 benchmark tests, MAPLE achieved a median absolute error of 1.6 years, outperforming five other competitive methods [4][12]. - MAPLE demonstrated excellent performance in disease risk assessment, with an average area under the curve (AUC) of 0.97 for disease identification and 0.85 for pre-disease state detection [4][19]. Group 3: Advantages of MAPLE - Traditional epigenetic clocks face challenges such as batch effects, which significantly hinder their clinical application [7][26]. - MAPLE's innovative approach focuses on relative relationships rather than absolute predictions, allowing for better comparability across diverse datasets [9][26]. - The two-stage training process of MAPLE enhances sample size and reduces overfitting risks, contributing to its superior performance [9][12]. Group 4: Clinical Applications and Future Prospects - MAPLE not only accurately predicts biological age but also serves as a health risk warning system, providing valuable time for early intervention [20][28]. - The framework is expected to play a crucial role in personalized anti-aging interventions, early disease risk screening, and understanding the biological mechanisms of aging [28]. - As MAPLE continues to be validated, it may become a standard component of health assessments, aiding in the management of healthy aging and offering new hope for age-related health challenges [28].

Core Viewpoint - The article discusses a study linking the dietary compound theobromine, found in cocoa, to a significant slowdown in epigenetic aging, suggesting potential health benefits related to diet and aging [1][3]. Group 1: Understanding Epigenetic Aging - Epigenetic aging refers to the biological age of an individual, which may differ from chronological age, as it is influenced by DNA modifications over time [5]. - The study utilized two well-known epigenetic clocks: GrimAge clock, which predicts lifespan and healthspan, and DNAmTL clock, which estimates telomere length, a marker of cellular aging [6][7]. Group 2: Key Findings - In the TwinsUK cohort of 509 healthy women, higher blood levels of theobromine were associated with a lower GrimAge acceleration and longer telomeres, indicating slower aging [9]. - The findings were replicated in the KORA cohort of 1160 individuals, confirming the robustness and universality of theobromine's anti-aging effects across different populations [9]. Group 3: Implications and Future Directions - The study suggests that theobromine's effects are specific and independent of other similar compounds like caffeine, reinforcing its unique role in aging [16]. - Future research should focus on clinical trials to directly test whether theobromine supplementation can actively slow epigenetic aging and explore the underlying molecular mechanisms [20].

Core Insights - The article discusses a significant research paper published in Cell Genomics, focusing on the multi-omic underpinnings of heterogeneous aging across multiple organ systems [4][6]. - The research aims to shift the paradigm of age-related disease management from a "divide and conquer" approach to a "unified prevention" strategy by understanding the molecular mechanisms of aging [7][9]. Research Objectives - The study aims to clarify the genetic associations between organ-specific aging and blood-based epigenetic aging, revealing phenotypic clusters related to heterogeneous aging across multiple organ systems [7]. - It seeks to identify candidate gene drug targets associated with these heterogeneous aging processes and evaluate opportunities for repurposing existing drugs [7]. - The research intends to uncover downstream proteomic and metabolomic effects driven by organ-specific and blood-based epigenetic aging, identifying detectable biomarkers [7]. - The study integrates findings to map the interaction networks of heterogeneous aging across multiple organ systems and their potential cross-layer molecular regulatory mechanisms [7][10]. Key Findings - The research team developed a framework based on R/Shiny, accessible online, providing a comprehensive multi-omic molecular map of heterogeneous aging [9]. - The study advances the understanding of aging heterogeneity, offering insights for precision medical strategies aimed at delaying organ-specific aging and preventing or treating related chronic diseases [9][10]. - Heterogeneous aging phenotypic clusters exhibit distinct biological characteristics, and genomic approaches have identified priority drug targets for addressing this aging heterogeneity [10].

Group 1 - The core idea of the article revolves around the identification of environmental factors that accelerate biological aging, which increases the risk of chronic diseases such as heart disease, cancer, and diabetes [1][2]. - A large-scale study conducted by Stanford University scientists analyzed thousands of middle-aged individuals to uncover unexpected factors contributing to accelerated aging [2][3]. Group 2 - The study utilized two main research tools: Exposome and epigenetic clocks to systematically investigate the relationship between environmental chemicals and aging [4][5][7][8]. - The Exposome encompasses all environmental factors a person is exposed to throughout their life, influencing gene activity and aging speed [5][6]. Group 3 - The research identified three major accelerators of aging: smoking, cadmium, and lead [13]. - Higher levels of cotinine, a metabolite of nicotine, were linked to increased biological aging, with a standard deviation increase in cotinine leading to a 1.40-year acceleration in the GrimAge clock [15][16][17]. Group 4 - Cadmium was found to be the most significant biological aging accelerator, with a standard deviation increase in serum cadmium resulting in a 1.23-year increase in GrimAge and a 0.02 unit increase in DunedinPoAm [19][20][21]. - Lead exposure was also significantly associated with accelerated aging, with a standard deviation increase in blood lead levels correlating to a 0.73-year increase in GrimAge [28][30]. Group 5 - Interestingly, exposure to certain toxic chemicals like dioxins and PCBs was associated with a decrease in epigenetic age, suggesting a complex relationship between toxicity and biological aging [33][34]. - The study proposed a "debt potential" hypothesis, where exposure to these toxins may lead to the production of younger immune cells as a compensatory mechanism [36][37]. Group 6 - Positive factors influencing slower aging included beneficial dietary components and higher socioeconomic status, which were linked to better health outcomes and slower biological aging [40][41][42]. - The research emphasized that individuals can actively manage their "exposome" to slow down aging, highlighting the importance of lifestyle choices such as quitting smoking and maintaining a diverse diet [45][48].

Group 1 - The core idea of the research is to identify environmental factors that accelerate biological aging, revealing that smoking, cadmium, and lead are significant contributors to accelerated aging [1][7][13]. - The study utilized two main research tools: exposome analysis and epigenetic clocks to assess the relationship between environmental chemicals and aging [4][5][6]. Group 2 - The exposome encompasses all environmental exposures from conception to death, influencing gene expression and aging speed [4]. - The epigenetic clocks measure biological age and health risks, with the second generation predicting health risks and the third generation measuring the speed of aging [5][6]. Group 3 - High levels of cotinine, a marker for tobacco exposure, correlate with increased biological aging, with each standard deviation increase in cotinine accelerating the death risk clock by 1.40 years [10][11]. - Cadmium is identified as the primary environmental factor accelerating biological aging, with each standard deviation increase in serum cadmium leading to significant increases in both death risk clocks [14][16]. Group 4 - Lead exposure is linked to accelerated aging, with each standard deviation increase in blood lead levels resulting in notable increases in death risk clocks [20][21]. - Interestingly, exposure to certain toxic chemicals like dioxins and PCBs was found to correlate with a decrease in epigenetic aging, suggesting a complex relationship between exposure and biological age [22][23]. Group 5 - The study highlights the importance of socioeconomic status and dietary choices in influencing aging speed, with higher income and better food choices associated with slower biological aging [26][27]. - The findings suggest that individuals can manage their aging process by making informed lifestyle choices, such as quitting smoking and diversifying their diet [28][29].

2015 年，韩国仁荷大学的研究人员在对公元 1392-1910 年之间的朝鲜皇家各成员血统纪录进行仔细分析 后发现，一个世纪前，太监 （被阉割的男性） 也比其他男性活得更久，其平均寿命要比正常男性长 14- 19 年。 不仅如此，阉割延长寿命这一观点在中国的封建王朝历史中也得到体现。据《中国帝王皇后亲王公主世系 录》记载，中国历代帝王平均寿命只有 40 岁，而那些服侍他们的太监，平均寿命却高达 71 岁。 而近期发表的一系列研究成果， 揭示了雄性寿命更短背后的"幕后黑手"—— 雄激素 。 编辑丨王多鱼 排版丨水成文 长寿长生是人类永恒的愿景。有趣的是，在哺乳动物中， 雌性通常比雄性寿命更长，人类也不例外 。据世 界卫生组织和联合国人口组织统计，全球范围内男性平均寿命比女性要短 5-10 年。据统计，2022 年中国 男性平均预期寿命为 76.5 岁，女性则为 82.9 岁，差距同样十分明显。 2023 年 5 月，得克萨斯大学圣安东尼奥健康科学中心长寿与衰老研究所的 James Nelson 教授团队在 Aging Cell 期刊发表了题为： Prepubertal castration eliminate ...